Benadryl (Diphenhydramine) Contraindications
Diphenhydramine should be avoided entirely—or used with extreme caution—in older adults, patients with glaucoma, benign prostatic hypertrophy/urinary retention, ischemic heart disease, uncontrolled hypertension, chronic obstructive pulmonary disease, dementia, cognitive impairment, and seizure disorders. 1
Absolute Contraindications
Glaucoma
- Diphenhydramine causes pupillary dilation through its anticholinergic effects and can precipitate acute angle-closure glaucoma. 1
- The FDA drug label explicitly warns against use in patients with glaucoma. 2
Benign Prostatic Hypertrophy and Urinary Retention
- Diphenhydramine's anticholinergic effects impair bladder contraction and can precipitate acute urinary retention, making this a major contraindication. 1
- The FDA label specifically warns against use in patients with "trouble urinating due to enlarged prostate gland." 2
- Up to 10% of acute urinary retention episodes may be attributable to anticholinergic medications like diphenhydramine. 3
Chronic Obstructive Pulmonary Disease and Asthma
- The FDA label warns against use in patients with "a breathing problem such as chronic bronchitis." 2
- Diphenhydramine can cause wheezing and respiratory complications. 1
Strong Relative Contraindications (Use with Extreme Caution)
Elderly Patients
- Older adults are at dramatically increased risk for delirium, cognitive decline, confusion, and falls when exposed to diphenhydramine. 1
- Hospitalized elderly patients receiving diphenhydramine have a 1.7-fold increased risk of any delirium symptoms (95% CI 1.3-2.3), with specific risks including inattention (RR 3.0), disorganized speech (RR 5.5), and altered consciousness (RR 3.1). 4
- A dose-response relationship exists for adverse cognitive outcomes in elderly patients. 4
- The American Geriatrics Society recommends avoiding diphenhydramine in older adults to prevent postoperative delirium. 5
Ischemic Heart Disease and Uncontrolled Hypertension
- The American Gastroenterological Association guidelines recommend extreme caution or avoidance in patients with ischemic heart disease or uncontrolled hypertension. 1
- Diphenhydramine can cause cardiac toxicity in overdose, including wide-complex tachycardia and QRS prolongation. 6
Dementia and Cognitive Impairment
- Dementia and cognitive impairment are strong relative contraindications given the high risk of delirium and further cognitive decline. 1
- Diphenhydramine is associated with increased risk of cognitive decline in hospitalized older patients. 4
Seizure Disorders
- The American Gastroenterological Association notes caution is warranted in patients with seizure disorders. 5
- Status epilepticus, though rare, has been reported following diphenhydramine overdose. 6
Important Drug Interactions
Avoid Combination With:
- Other anticholinergic agents (cyclobenzaprine, oxybutynin, prochlorperazine, promethazine, tricyclic antidepressants, paroxetine) due to additive anticholinergic effects. 5, 1
- Alcohol, sedatives, benzodiazepines, and opioid narcotics, as diphenhydramine's hypnotic and sedative effects are significantly increased with these combinations. 1, 2
- The FDA label explicitly warns that "alcohol, sedatives, and tranquilizers may increase drowsiness." 2
Critical Monitoring Parameters When Use Cannot Be Avoided
Anticholinergic Toxicity Assessment
- Monitor for urinary retention, constipation, dry mouth, blurred vision, and delirium. 1
- Watch for paradoxical reactions including increased agitation and rage, particularly in children and adolescents. 1
- Assess for hypotension, especially when given intravenously or with other CNS depressants. 1
Cardiovascular Monitoring
- Monitor blood pressure for hypotension and heart rate for tachycardia. 1
- In overdose situations, obtain ECG to assess for QRS widening and consider sodium bicarbonate therapy if wide-complex tachycardia develops. 6
Special Population Considerations
Pregnancy and Breastfeeding
- The FDA label advises asking a healthcare professional before use if pregnant or breastfeeding. 2
Renal Impairment
- While not an absolute contraindication, elderly patients with renal insufficiency may have prolonged effects and increased sensitivity to anticholinergic adverse effects. 1
Common Clinical Pitfalls
- Inappropriate prescribing: Studies show 24% of diphenhydramine doses in hospitalized elderly patients are administered inappropriately. 4
- Polypharmacy concerns: Avoid prescribing diphenhydramine with other anticholinergic medications, as additive effects dramatically increase risk. 1
- Duration of effect: The 4-6 hour duration often exceeds the time needed for symptom control, potentially extending recovery time and adverse effects. 1
- Availability of safer alternatives: Second-generation antihistamines are widely available, affordable, and have fewer adverse effects, making diphenhydramine increasingly obsolete for most indications. 7